Back to Search
Start Over
The Soon-To-Be Reality Of Medicare Part B Reimbursements For Biosimilars
- Source :
- Mondaq Business Briefing. May 6, 2015
- Publication Year :
- 2015
-
Abstract
- As the country's largest health insurer, Medicare has immense influence on the health care market. In the wake of the recent approval of Sandoz's Zarxio (filgrastim-sndz), the first FDA-approved biosimilar, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Mondaq Business Briefing
- Publication Type :
- News
- Accession number :
- edsgcl.412489646